March 04, 2025 07:06 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Haryana Congress worker murder: Video emerges showing accused dragging suitcase with Himani Narwal's body inside it | Supreme Court slams 'oversmart' Samay Raina for making fun of proceedings in Canada, asks him to 'behave' | Indian woman facing death row in UAE for killing a child has been executed: Foreign ministry tells court | Crucial to have Trump’s support, says Zelenskyy a day after fiery White House exchange | 'We're looking for peace, Zelenskyy wants Russia-Ukraine war to continue': Donald Trump after White House public spat | Volodymyr Zelenskyy refuses to apologise to Donald Trump after public spat over Russia-Ukraine war | 'Make a deal or we are out': Donald Trump tells Volodymyr Zelenskyy at White House | Himachal govt seeks fund from temple to support welfare schemes, BJP calls move 'shocking' | Injustice to opposition MLAs: Atishi writes to Delhi Assembly Speaker on suspension of 21 AAP lawmakers | We will leave for US tomorrow: Father of Indian student Neelam Shinde after urgent visa grant
Covid-19 Vaccine
Image Credit: Firhad Hakim Twitter

Kolkata: Firhad Hakim gets vaccinated in Covaxin's phase 3 trial

| @indiablooms | Dec 02, 2020, at 11:42 pm

Kolkata/IBNS: Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, on Wednesday got vaccinated in the third phase of trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

The third phase trial was inaugurated in the city by West Bengal Governor Jagdeep Dhankhar at Kolkata's National Institute of Cholera and Enteric Disease (NICED)  on Tuesday.

After getting vaccinated, Hakim, who became the second candidate to take the dose of Covaxin in the trial, said, "I am fully fine after getting vaccinated."

"I don't care even if I die. My vaccination will be fruitful when the entire country will get vaccinated," he said.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.